150 related articles for article (PubMed ID: 37163779)
1. Oxidative stress: A common pathological state in a high-risk population for osteoporosis.
Zhang C; Li H; Li J; Hu J; Yang K; Tao L
Biomed Pharmacother; 2023 Jul; 163():114834. PubMed ID: 37163779
[TBL] [Abstract][Full Text] [Related]
2. Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation.
Xu Y; Song D; Lin X; Peng H; Su Y; Liang J; Hai N; Zhao J; Liu Q
Free Radic Biol Med; 2023 Feb; 196():121-132. PubMed ID: 36649902
[TBL] [Abstract][Full Text] [Related]
3. Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs.
Iantomasi T; Romagnoli C; Palmini G; Donati S; Falsetti I; Miglietta F; Aurilia C; Marini F; Giusti F; Brandi ML
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835184
[TBL] [Abstract][Full Text] [Related]
4. TNF-α Inhibits FoxO1 by Upregulating miR-705 to Aggravate Oxidative Damage in Bone Marrow-Derived Mesenchymal Stem Cells during Osteoporosis.
Liao L; Su X; Yang X; Hu C; Li B; Lv Y; Shuai Y; Jing H; Deng Z; Jin Y
Stem Cells; 2016 Apr; 34(4):1054-67. PubMed ID: 26700816
[TBL] [Abstract][Full Text] [Related]
5. Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways.
Qin Y; Song D; Liao S; Chen J; Xu M; Su Y; Lian H; Peng H; Wei L; Chen K; Xu J; Zhao J; Liu Q
Biomed Pharmacother; 2023 Apr; 160():114347. PubMed ID: 36746095
[TBL] [Abstract][Full Text] [Related]
6. Purine metabolism in the development of osteoporosis.
Yang K; Li J; Tao L
Biomed Pharmacother; 2022 Nov; 155():113784. PubMed ID: 36271563
[TBL] [Abstract][Full Text] [Related]
7. MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL-Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway.
Wang Y; Li X; Zhou S; Li J; Zhu Y; Wang Q; Zhao F
Oxid Med Cell Longev; 2022; 2022():7727006. PubMed ID: 36148414
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol promotes osteogenesis via activating SIRT1/FoxO1 pathway in osteoporosis mice.
Jiang Y; Luo W; Wang B; Wang X; Gong P; Xiong Y
Life Sci; 2020 Apr; 246():117422. PubMed ID: 32057903
[TBL] [Abstract][Full Text] [Related]
9. Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.
Chen K; Qiu P; Yuan Y; Zheng L; He J; Wang C; Guo Q; Kenny J; Liu Q; Zhao J; Chen J; Tickner J; Fan S; Lin X; Xu J
Theranostics; 2019; 9(6):1634-1650. PubMed ID: 31037128
[No Abstract] [Full Text] [Related]
10. Resveratrol Ameliorates High Altitude Hypoxia-Induced Osteoporosis by Suppressing the ROS/HIF Signaling Pathway.
Yan C; Wang Z; Liu W; Pu L; Li R; Ai C; Xu H; Zhang B; Wang T; Zhang X; Chen Z; Wang X
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080305
[TBL] [Abstract][Full Text] [Related]
11. Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis.
Yang K; Cao F; Xue Y; Tao L; Zhu Y
Front Physiol; 2022; 13():840293. PubMed ID: 35309045
[TBL] [Abstract][Full Text] [Related]
12. Probucol suppresses osteoclastogenesis via activating Nrf2 signaling and ameliorates ovariectomy-induced bone loss.
Guo J; Ren R; Guo Z; Sun K; He J; Shao J; Wang X
Int Immunopharmacol; 2023 Mar; 116():109820. PubMed ID: 36758295
[TBL] [Abstract][Full Text] [Related]
13. Autophagy in Bone Remodeling: A Regulator of Oxidative Stress.
Zhu C; Shen S; Zhang S; Huang M; Zhang L; Chen X
Front Endocrinol (Lausanne); 2022; 13():898634. PubMed ID: 35846332
[TBL] [Abstract][Full Text] [Related]
14. Trimethylamine-N-Oxide Promotes Osteoclast Differentiation and Bone Loss via Activating ROS-Dependent NF-κB Signaling Pathway.
Wang N; Hao Y; Fu L
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235607
[TBL] [Abstract][Full Text] [Related]
15. The Role of AOPP in Age-Related Bone Loss and the Potential Benefits of Berry Anthocyanins.
Melough MM; Sun X; Chun OK
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28737666
[TBL] [Abstract][Full Text] [Related]
16. Anti-osteoporosis effects of osteoking via reducing reactive oxygen species.
Qin D; Zhang H; Zhang H; Sun T; Zhao H; Lee WH
J Ethnopharmacol; 2019 Nov; 244():112045. PubMed ID: 31260757
[TBL] [Abstract][Full Text] [Related]
17. A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-
Wong P; Lv Z; Li J; Wei Q; Xu L; Fang B; Luo Y; He M
Oxid Med Cell Longev; 2022; 2022():5982014. PubMed ID: 36388169
[TBL] [Abstract][Full Text] [Related]
18. Conditioned Medium from Bone Marrow Mesenchymal Stem Cells Restored Oxidative Stress-Related Impaired Osteogenic Differentiation.
Saleem R; Mohamed-Ahmed S; Elnour R; Berggreen E; Mustafa K; Al-Sharabi N
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948255
[TBL] [Abstract][Full Text] [Related]
19. AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis.
Yang S; Song D; Wang Z; Su Y; Chen J; Xian Y; Huang J; Li J; Xu J; Zhao J; Liu Q
Int Immunopharmacol; 2022 Dec; 113(Pt A):109370. PubMed ID: 36327872
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress in bone remodeling: role of antioxidants.
Domazetovic V; Marcucci G; Iantomasi T; Brandi ML; Vincenzini MT
Clin Cases Miner Bone Metab; 2017; 14(2):209-216. PubMed ID: 29263736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
